Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Fresenius Kabi Austria GmbH currently manages 4 pending office actions within the Biotechnology & Pharmaceuticals technology area. This workload is distributed across 4 distinct examiners, which indicates the portfolio is not overseen by an individual. The prosecution activity is located within 2 distinct art units, showing the technical scope of these filings. Practitioners should note the ratio of examiners to art units, as this may lead to varied examination styles within the specified technology area.
OLSEN, KAELEIGH ELIZABETH is identified as the busiest examiner for the company, and she is responsible for 1 pending office action. This distribution shows that no individual examiner holds all pending matters, as the actions are split among the distinct examiners. The presence of 2 distinct art units suggests that while the examiners are different, they operate within a limited number of departments. This balance between multiple examiners and the art units requires a strategy that accounts for individual examiner tendencies while maintaining consistency across the portfolio.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 4 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OLSEN, KAELEIGH ELIZABETH | 1 | 50.0% | +61.5% |
| KWON, YONG SOK | 1 | 24.6% | +42.7% |
| O DELL, DAVID K | 1 | 57.7% | +36.0% |
| WHEELER, THURMAN MICHAEL | 1 | 45.8% | +23.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18715677 | EPHEDRINE LIQUID FORMULATIONS | OLSEN, KAELEIGH ELIZABETH | — |
| 18705423 | PHYTONADIONE FOR PARENTERAL ADMINISTRATION | KWON, YONG SOK | — |
| 18572334 | AQUEOUS, ROOM-TEMPERATURE STABLE ROCURONIUM COMPOSITION | O DELL, DAVID K | — |
| 17787478 | METHODS FOR PRODUCING OIL-IN-WATER EMULSIONS | WHEELER, THURMAN MICHAEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18715677 | EPHEDRINE LIQUID FORMULATIONS | OLSEN, KAELEIGH ELIZABETH | — |
| 18705423 | PHYTONADIONE FOR PARENTERAL ADMINISTRATION | KWON, YONG SOK | — |
| 18572334 | AQUEOUS, ROOM-TEMPERATURE STABLE ROCURONIUM COMPOSITION | O DELL, DAVID K | — |
| 17787478 | METHODS FOR PRODUCING OIL-IN-WATER EMULSIONS | WHEELER, THURMAN MICHAEL | — |
| Art Unit | Apps |
|---|---|
| 1619 | 2 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18715677 | EPHEDRINE LIQUID FORMULATIONS | OLSEN, KAELEIGH ELIZABETH | 1619 | §103§112 | Non-Final OA | — | Pending | May 31, 2024 |
| 18705423 | PHYTONADIONE FOR PARENTERAL ADMINISTRATION | KWON, YONG SOK | — | §103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18572334 | AQUEOUS, ROOM-TEMPERATURE STABLE ROCURONIUM COMPOSITION | O DELL, DAVID K | 1621 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2023 |
| 17787478 | METHODS FOR PRODUCING OIL-IN-WATER EMULSIONS | WHEELER, THURMAN MICHAEL | 1619 | §103§112 | Non-Final OA | — | Pending | Jun 20, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial